The Aducanumab Biosimilar Anti-APP Antibody offered by Assay Genie is a cutting-edge tool for researchers studying Alzheimer's disease and other neurodegenerative disorders. This monoclonal antibody is specifically designed to target amyloid precursor protein (APP), a key player in the pathogenesis of Alzheimer's disease.The antibody is rigorously validated for use in various applications, including immunohistochemistry, immunofluorescence, and ELISA, allowing for precise and reliable detection of APP in experimental samples. With its high specificity and sensitivity, researchers can confidently explore the role of APP in disease progression and potential therapeutic interventions.
By utilizing the Aducanumab Biosimilar Anti-APP Antibody, researchers can delve deeper into the mechanisms underlying Alzheimer's disease and develop novel strategies for diagnosis and treatment. This innovative tool promises to advance the field of neurodegenerative research and pave the way for new breakthroughs in understanding and combating this devastating condition.
Product Name:
Aducanumab (Anti-APP) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0122
Target:
APP
Host Species:
Homo sapiens
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BART, BIIB-037, BIIB037, aducanumab-avwa
Description:
Anti-APP(aducanumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
